Header Logo

Connection

Barish Edil to Melanoma, Experimental

Back to Details
This is a "connection" page, showing publications Barish Edil has written about Melanoma, Experimental.
Barish Edil
Connection Strength
0.038
Melanoma, Experimental
  1. Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity. Cancer Res. 2018 12 01; 78(23):6655-6665.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.